Delivery Order SPE2DB24D2106-SPE2DB25FAVQT
- Not listed
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Quillivant XR 25 mg/5 ml suspension (120 ml) with a ceiling value of $2,217.66. The award, finalized on September 10, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 11, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order was...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $1,314.20, is for the supply of Quillivant XR 25 mg/5 ml suspension (120 ml) and has a period of performance through May 13, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999, which enables the agency to issue...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,366.07 contract is for the supply of Quillivant XR 25 mg/5 ml suspension (120 ml) with a performance period ending on May 20, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue delivery orders for a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles, with a ceiling value of $2,412.14 and a completion date of July 3, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois that specializes in providing a range of pharmaceutical products to federal...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,440.48 contract is for the delivery of Quillivant XR 25 mg/5 ml suspension in a 150 ml bottle. The contract has an ultimate completion date of March 3, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $1,314.20, is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. This contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- This federal contract award issued by the Defense Logistics Agency (DLA) is a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,537.17 contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a specialized prescription medication. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
- This is a delivery order contract (SPE2DB20D6037|SPE2DB25FTUE9) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,051.36 firm fixed-price contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,231.66 by the Defense Logistics Agency on August 12, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml quantities. The contract carries no set-aside designation and is scheduled for completion by August 13, 2025, with performance to take place in Conshohocken, Pennsylvania. This delivery order is issued...
- This federal contract award issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The contract is a firm fixed-price delivery order with a ceiling value of $1,631.03 and a completion date of October 29, 2024. DMS Pharmaceutical Group Inc. is the prime contractor and this order is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) the company...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAVQTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,157.48 to DMS Pharmaceutical Group Inc. for Quillivant XR 25 mg/5 ml suspension (120 ml), with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was issued without set-aside designation and represents a single product delivery to support federal pharmaceutical supply needs. The place of performance is listed in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor on this delivery order. The company operates under a significant single-award Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for pharmaceutical products supporting military health facilities worldwide. This delivery order exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, providing prescription medications and medical supplies directly to Department of Defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/25/25 |